| Lastest Insider Transactions Of FATE THERAPEUTICS INC ( FATE ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | 2026-08-04 | Sell | 38,800 | 2.46 | 95,405 | 2026-08-05 16:03:45 |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | President and CEO | 2026-08-04 | Sell | 43,947 | 2.46 | 108,101 | 2026-08-05 16:01:39 |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | 2026-05-20 | Sell | 25,590 | 1.88 | 48,084 | 2026-05-21 16:02:44 |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | President and CEO | 2026-05-20 | Sell | 28,946 | 1.88 | 54,482 | 2026-05-21 16:01:08 |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | 2026-05-06 | Option Exercise | 166,664 | 1.25 | 207,997 | 2026-05-07 16:00:36 |
| FATE | FATE THERAPEUTICS INC | EPSTEIN ROBERT S | Directior | 2026-05-05 | Option Exercise | 25,000 | 1.69 | 42,250 | 2026-05-06 16:01:46 |
| FATE | FATE THERAPEUTICS INC | RASTETTER WILLIAM H | Directior | 2026-05-05 | Option Exercise | 25,000 | 1.69 | 42,250 | 2026-05-06 16:00:22 |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | 2026-01-09 | Sell | 10,589 | 1.06 | 11,275 | 2026-01-12 16:04:22 |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | President and CEO | 2026-01-09 | Sell | 5,190 | 1.07 | 5,557 | 2026-01-12 16:03:31 |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | 2025-08-04 | Sell | 9,037 | 1.06 | 9,573 | 2025-08-05 16:03:43 |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | 2025-08-04 | Sell | 9,037 | 1.06 | 9,573 | 2025-08-05 16:03:43 |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | President and CEO | 2025-08-04 | Sell | 14,466 | 1.06 | 15,396 | 2025-08-05 16:02:34 |
| FATE | FATE THERAPEUTICS INC | Bressi Jerome Charles | See Remarks | 2025-01-10 | Sell | 5,980 | 1.55 | 9,269 | 2025-01-13 16:06:16 |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | 2025-01-10 | Sell | 5,654 | 1.55 | 8,764 | 2025-01-13 16:05:23 |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | President and CEO | 2025-01-10 | Sell | 8,705 | 1.54 | 13,406 | 2025-01-13 16:04:38 |
| FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Directior 10% Owner | 2024-12-20 | Buy | 397,964 | 1.68 | 668,580 | 2024-12-26 21:00:15 |
| FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Directior 10% Owner | 2024-12-20 | Sell | 341,633 | 1.68 | 573,943 | 2024-12-26 21:00:15 |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Directior | 2024-08-06 | Sell | 633 | 4.23 | 2,678 | 2024-08-07 16:01:01 |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Directior | 2024-08-06 | Sell | 633 | 4.23 | 2,678 | 2024-08-07 16:01:01 |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Directior | 2024-08-06 | Sell | 633 | 4.23 | 2,678 | 2024-08-07 16:01:01 |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Directior | 2024-08-06 | Sell | 633 | 4.23 | 2,678 | 2024-08-07 16:01:01 |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Directior | 2024-08-06 | Sell | 633 | 4.23 | 2,678 | 2024-08-07 16:01:01 |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Directior | 2024-08-06 | Sell | 633 | 4.23 | 2,678 | 2024-08-07 16:01:01 |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Directior | 2024-08-06 | Sell | 633 | 4.23 | 2,678 | 2024-08-07 16:01:01 |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Directior | 2024-08-06 | Sell | 633 | 4.23 | 2,678 | 2024-08-07 16:01:01 |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Directior | 2024-08-06 | Sell | 633 | 4.23 | 2,678 | 2024-08-07 16:01:01 |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Directior | 2024-08-06 | Sell | 633 | 4.23 | 2,678 | 2024-08-07 16:01:01 |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Directior | 2024-08-06 | Sell | 633 | 4.23 | 2,678 | 2024-08-07 16:01:01 |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Directior | 2024-08-06 | Sell | 633 | 4.23 | 2,678 | 2024-08-07 16:01:01 |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | 2024-03-04 | Sell | 2,447 | 7.77 | 19,013 | 2024-03-05 16:24:31 |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | 2024-01-29 | Sell | 1,849 | 5.00 | 9,245 | 2024-01-30 16:01:19 |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | 2024-01-09 | Sell | 10,874 | 4.37 | 47,519 | 2024-01-10 16:30:36 |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief R&D Officer | 2024-01-09 | Sell | 11,271 | 4.38 | 49,367 | 2024-01-10 16:30:15 |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | 2024-01-09 | Sell | 14,391 | 4.37 | 62,889 | 2024-01-10 16:29:56 |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | 2024-01-09 | Sell | 7,028 | 4.37 | 30,712 | 2024-01-10 16:29:38 |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | 2024-01-02 | Sell | 5,182 | 3.66 | 18,966 | 2024-01-03 16:03:17 |
| FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Directior 10% Owner | 2023-12-26 | Buy | 44,630 | 3.72 | 166,024 | 2023-12-28 21:30:16 |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | 2023-12-18 | Sell | 1,585 | 3.50 | 5,548 | 2023-12-19 16:01:11 |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | 2023-11-09 | Sell | 24,363 | 2.40 | 58,471 | 2023-11-13 16:01:53 |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | 2023-08-18 | Sell | 4,718 | 2.80 | 13,210 | 2023-08-21 16:02:44 |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Directior | 2023-08-04 | Sell | 632 | 3.71 | 2,345 | 2023-08-07 16:01:00 |
| FATE | FATE THERAPEUTICS INC | Powl Brian T. | Chief Commercial Officer | 2023-07-05 | Sell | 3,854 | 4.87 | 18,769 | 2023-07-06 17:19:21 |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | 2023-07-05 | Sell | 5,182 | 4.83 | 25,029 | 2023-07-06 17:18:18 |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Directior | 2023-06-14 | Sell | 3,460 | 5.58 | 19,307 | 2023-06-15 16:05:31 |
| FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Directior 10% Owner | 2023-04-20 | Buy | 276,639 | 6.17 | 1,705,829 | 2023-04-21 21:55:13 |
| FATE | FATE THERAPEUTICS INC | Chu Yu-Waye | Chief Medical Officer | 2023-04-18 | Sell | 2,532 | 6.57 | 16,648 | 2023-04-19 16:07:25 |
| FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Directior 10% Owner | 2023-04-13 | Buy | 25,700 | 6.00 | 154,200 | 2023-04-17 21:30:24 |
| FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Directior 10% Owner | 2023-04-13 | Sell | 302,339 | 5.84 | 1,765,660 | 2023-04-17 21:30:24 |
| FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Directior | 2023-01-19 | Option Exercise | 28,461 | 1.37 | 38,992 | 2023-01-20 16:14:33 |
| FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Directior | 2023-01-11 | Buy | 124,679 | 5.60 | 698,139 | 2023-01-13 18:20:08 |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief R&D Officer | 2023-01-12 | Option Exercise | 423 | 1.37 | 580 | 2023-01-13 16:02:47 |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | 2023-01-10 | Sell | 45,907 | 5.24 | 240,553 | 2023-01-11 16:09:38 |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief R&D Officer | 2023-01-10 | Sell | 10,917 | 5.24 | 57,205 | 2023-01-11 16:08:52 |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | 2023-01-10 | Sell | 11,553 | 5.24 | 60,538 | 2023-01-11 16:08:03 |
| FATE | FATE THERAPEUTICS INC | Plavsic Mark | Chief Technical Officer | 2023-01-10 | Sell | 3,418 | 5.24 | 17,910 | 2023-01-11 16:07:13 |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | 2023-01-10 | Sell | 7,331 | 5.24 | 38,414 | 2023-01-11 16:06:43 |
| FATE | FATE THERAPEUTICS INC | Chu Yu-Waye | Chief Medical Officer | 2023-01-10 | Sell | 7,825 | 5.24 | 41,003 | 2023-01-11 16:05:56 |
